Objectives: to examine the outcome and incidence of access-related procedures in patients who
Introduction
performed on patients who ultimately require synthetic access-graft placement. We also examined overIncreasing acceptance of elderly patients onto dialysis all patient outcome in this difficult group of patients. programmes and improved dialysis therapy has resulted in more patients receiving treatment for endstage renal failure (ESRF). World-wide the incidence Patients and Method of treated ESRF is expected to double in the last decade of this century. 1 The continuing shortage of organs We conducted a retrospective case note study of all for renal transplantation means that many patients patients who received a polytetrafluoroethylene accepted for ESRF treatment face life-long haemo-(PTFE, Impra) haemodialysis graft, placed between dialysis. Autologous fistula is the optimal method of July 1991 and July 1996. Graft placements were idenhaemodialysis access. 2 In patients who do not have tified through the renal unit computerised database suitable veins, or to avoid the need to await fistula and operation records. maturation, haemodialysis access may require the use Patients underwent access-grafting following failure of synthetic grafts (secondary access), or central lines. of native arteriovenous fistula (AVF) or failure of such The results of secondary access procedures vary, prob-fistula to mature. It was our policy to exhaust forearm ably due to the indications for placement and how and antecubital fossa veins prior to placement of access aggressively graft malfunction is treated.
grafts. Thigh grafts were used when arm veins were We examined the morbidity associated with failure absent or arm-swelling prevented their use. Armto establish a native arteriovenous fistula. Our study swelling was seen in some patients who had underfocused on the number of access-related procedures gone numerous subclavian-line placements and was presumed to be secondary to central venous stenosis. Duplex scanning and venography were not routinely used during the period under study. All graft place- new site of access. 
Results

function.
In total there were 104 grafts placed in 72 patients in Grafts were placed in the forearm, wherever a suitHaemorrhage 4 able artery and vein could be identified. There were Steal 1 21 straight forearm grafts from radial artery to a vein in the antecubital fossa. A further 21 grafts were placed in a forearm loop configuration between brachial artery and an antecubital vein. The majority of grafts (n= months (Table 1) . There was no significant difference in 45) were placed in an upper arm straight configuration secondary patency rates between graft configurations between the brachial artery in the antecubital fossa (log rank test). and the basilic or brachial vein at the level of the axillary floor. Seventeen femoral artery to long saphenous vein thigh-loop grafts were also placed ( Fig. 1) .
Graft malfunction
During the study period there were 51 grafts that required intervention for malfunction as shown in Graft survival complications and interventions Table 2 . The commonest cause of graft failure was thrombosis caused by outflow vessel stenosis or thromThe overall one-year secondary patency across all graft types was 56% (Fig. 2) . Mean graft patency was 20.4 bosis during low flow states associated with post- dialysis hypotension. Graft sepsis was the second commonest cause of graft failure (21% of grafts) (Fig. 3) . In total, there were 54 interventions for graft malfunction. Fourteen patients required a total of 22 two with functioning access grafts. Two patients were interventions for graft occlusion. Simple graft throm-dialysing through an autologous fistula. Five patients bectomy was performed in 12 cases, thrombolysis were wholly dependent on central venous catheters in one, and in nine cases graft thrombectomy was (Table 3) . combined with a procedure to treat outflow obThese 72 patients who underwent synthetic access struction (thrombectomy plus skip graft n=7, throm-grafting had been treated for a total of 383 years, since bectomy plus angioplasty n=2).
onset of haemodialysis. In this time a total of 639 Graft occlusions treated by thrombectomy or lysis procedures were performed to maintain haemodialysis alone all rapidly re-occluded (time to re-occlusion access (Table 4) . median 18 days, interquartile range (IQR) 39, n=13). Where thrombectomy was combined with an outflow procedure there was a trend to better long-term patency, with the median time to re-occlusion being 210
Transplant history days (IQR 112, n=4). Five grafts were still patent at the end of the study period after a median follow-up Of the 72 patients in this study, 25 patients had received of 317 days (IQR 208, n=5) . a total of 34 renal transplants at some time during Fourteen patients underwent 21 operative pro-their treatment for renal failure. In the patients studied, cedures for graft sepsis, in one case complicated by 18 had received one transplant, five had been transhaemorrhage. In 17 cases the grafts were excised and planted twice and two patients had been transplanted a new graft sited elsewhere. On four occasions grafts three times. were successfully treated by local debridement comOnly six patients received a renal transplant folbined with excision and replacement of infected sec-lowing a secondary access procedure. tions of graft. Thigh grafts had the highest rate of interventions for graft sepsis. The commonest infecting organisms were Staphylococci and Coliform sp.
All patients in whom grafts required re-exploration, Incidence of secondary access procedures for thrombosis or re-siting, were anticoagulated.
During the study period there was an increase in the number of patients treated by haemodialysis by our Patient outcome unit. This has been caused by an increase in demand for dialysis. The number of secondary access placeAt the end of the study period, 48 patients were still dialysing via an access graft. Eleven patients had died, ments has risen rapidly during this period. The number rection of outflow tract abnormality is essential if revision procedures are to be successful. It has been proposed that it is more effective to replace rather than revise thrombosed access grafts.
7 During the period under study five of our patients had exhausted all potential sites for definitive access procedures and were wholly reliant on central venous catheters. Patient access opportunities are finite and all attempts should be made to prolong the use of an access site before using a new graft site.
Graft sepsis accounted for 21% of graft failures. In particular, thigh grafts had a high incidence of graft sepsis. Attempts to lessen graft sepsis may contribute to improving the results of secondary access pro- onstrated resistance to infection in both haemodialysis 8 and peripheral vascular surgery. In patients and graft sites susceptible to infection, vein allografts may offer of patients treated by haemodialysis with the number an alternative to PTFE grafts. This area merits further of PTFE access grafts and transplants is shown in Fig. research. 
4.
Conclusions Discussion
The increasing number of patients coming to synthetic The rise in the haemodialysis population is not being access-grafts procedures and the morbidity of such accompanied by a commensurate rise in the number procedures mean that surgeons should adopt stratof transplants. We have seen that secondary access egies to minimise the use of grafts. Careful planning recipients are a selected population with a low prob-will also reduce the number of central line placements ability of obtaining a functioning renal transplant. and help to reduce the morbidity associated with longDespite a policy of aggressive use of native vessel term haemodialysis. arteriovenous fistula, our unit is seeing a relentless rise in the need for synthetic access grafts.
Secondary access-graft recipients have a high accessrelated morbidity with numerous interventions re
